Variability in the Definition and Reporting of Adverse Events in Suicide Prevention Trials: An Examination of the Issues and a Proposed Solution

被引:6
作者
Oquendo, Maria A. [1 ]
Feldman, Sarah [1 ]
Silverman, Emily [1 ]
Currier, Dianne [2 ]
Brown, Gregory K. [3 ]
Chen, Donna [4 ]
Chiapella, Page [5 ]
Fischbach, Ruth [1 ]
Gould, Madelyn [1 ]
Stanley, Barbara [1 ]
Strauss, David [1 ]
Zelazny, Jamie [6 ]
Pearson, Jane [7 ]
机构
[1] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
[2] Columbia Univ, Dept Psychiat, New York, NY USA
[3] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[4] Univ Virginia, Ctr Biomed Eth & Humanities, Charlottesville, VA USA
[5] NIAAA, Bethesda, MD USA
[6] Univ Pittsburgh, Pittsburgh, PA USA
[7] NIMH, Bethesda, MD 20892 USA
关键词
Adverse Events; safety; Serious Adverse Events; study evaluation; suicide research; TOWER-OF-BABEL; CLINICAL-TRIALS; SAFETY; INTERVENTION; NOMENCLATURE; MULTICENTER; IMPROVEMENT; BEHAVIOR; LESSONS; CARE;
D O I
10.1080/13811118.2011.541146
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Adverse events (AEs) and serious adverse events (SAEs) are important outcomes of any intervention study yet are under-researched. Vague and variable definitions and substantial underreporting make comparisons of risk between studies difficult and evaluation of the safety of a particular intervention almost impossible. These realities may deter researchers from studying at-risk populations. Suicidal behavior is an adverse event in any study, and potentially a very serious one. Thus the issues of reporting and definition are particularly salient for researchers who work with populations at risk for suicidal behavior, especially when the suicidal behavior is the outcome of interest. We conducted a qualitative study with experienced suicide researchers and intervention experts to delineate the issues related to reporting serious adverse events faced by investigators conducting trials in suicide prevention. Participants from multiple sites were interviewed by phone, interviews transcribed and coded for definition and reporting issues and suggested solutions. A narrative synthesis was prepared and validated by all participants. Participants highlighted the difficulties in defining AEs and SAEs and stressed the importance and complexity of ensuring the AE was related to the study and reported properly, and were in agreement about the consequences of AEs to both institutions and individuals. Participants identified the need for the development of clear and consistent AE definitions and reporting requirements. Clear and consistently applied definitions of adverse and serious adverse events and reporting requirements would enhance the comparability of intervention studies in suicidal populations.
引用
收藏
页码:29 / 42
页数:14
相关论文
共 50 条
  • [1] Reporting of adverse events in cognitive behavioural therapy for insomnia: A systematic examination of randomised controlled trials
    Condon, Heather E.
    Maurer, Leonie F.
    Kyle, Simon D.
    SLEEP MEDICINE REVIEWS, 2021, 56
  • [2] Monitoring adverse social and medical events in public health trials: assessing predictors and interpretation against a proposed model of adverse event reporting
    Moody, Gwenllian
    Addison, Katy
    Cannings-John, Rebecca
    Sanders, Julia
    Wallace, Carolyn
    Robling, Michael
    TRIALS, 2019, 20 (01)
  • [3] Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trials
    Lopes, Guilherme S.
    Tournigand, Christophe
    Olswold, Curtis L.
    Cohen, Romain
    Kempf, Emmanuelle
    Saltz, Leonard
    Goldberg, Richard M.
    Hurwitz, Herbert
    Fuchs, Charles
    de Gramont, Aimery
    Shi, Qian
    CLINICAL TRIALS, 2021, 18 (01) : 51 - 60
  • [4] Reporting of adverse events associated with spinal manipulation in randomised clinical trials: an updated systematic review
    Gorrell, Lindsay M.
    Brown, Benjamin T.
    Engel, Roger
    Lystad, Reidar P.
    BMJ OPEN, 2023, 13 (05):
  • [5] Improving the capture and reporting of adverse events in clinical trials of non-pharmacological interventions: learnings from the PaCCSC/CST membership
    Saleh Moussa, Rayan
    Power, Jack
    Yenson, Vanessa
    Fazekas, Belinda
    Marston, Celia
    Hosie, Annmarie
    Edwards, Layla
    Disalvo, Domenica
    Brown, Linda
    Gilmore, Imelda
    Stubbs, John
    Cross, Andrea
    Fielding, Sally
    Agar, Meera R.
    TRIALS, 2025, 26 (01)
  • [6] Analysis of adverse events attribution and reporting in cancer clinical trials: A systematic review
    Enrico, Diego
    Waisberg, Federico
    Burton, Jeannette
    Mando, Pablo
    Chacon, Matias
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 160
  • [7] Adverse events in anaesthetic practice: qualitative study of definition, discussion and reporting
    Smith, AF
    Goodwin, D
    Mort, M
    Pope, C
    BRITISH JOURNAL OF ANAESTHESIA, 2006, 96 (06) : 715 - 721
  • [8] Collecting and reporting adverse events in low-income settings-perspectives from vaccine trials in the Gambia
    Bruce, Andrew Ayi-Ashong
    Umesi, Ama-Onyebuchi
    Bashorun, Adedapo
    Ochoge, Magnus
    Yisa, Mohammed
    Obayemi-Ajiboye, Dolapo
    Futa, Ahmed
    Njie, Anna
    Asase, Selasi
    Jallow, Modou Bella
    Kotei, Larry
    Affleck, Lucy
    Olubiyi, Olubunmi Abiola
    Jarju, Lamin B.
    Kanyi, Madi
    Danso, Baba
    Zemsi, Armel
    Clarke, Ed
    TRIALS, 2024, 25 (01)
  • [9] Adverse Events Reporting of Clinical Trials in Exercise Oncology Research (ADVANCE): Protocol for a Scoping Review
    Luo, Hao
    Schumacher, Oliver
    Galvao, Daniel A.
    Newton, Robert U.
    Taaffe, Dennis R.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] The reporting of adverse events following spinal manipulation in randomized clinical trials-a systematic review
    Gorrell, Lindsay M.
    Engel, Roger M.
    Brown, Benjamin
    Lystad, Reidar P.
    SPINE JOURNAL, 2016, 16 (09) : 1143 - 1151